AU2003205230A1 - Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes - Google Patents
Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetesInfo
- Publication number
- AU2003205230A1 AU2003205230A1 AU2003205230A AU2003205230A AU2003205230A1 AU 2003205230 A1 AU2003205230 A1 AU 2003205230A1 AU 2003205230 A AU2003205230 A AU 2003205230A AU 2003205230 A AU2003205230 A AU 2003205230A AU 2003205230 A1 AU2003205230 A1 AU 2003205230A1
- Authority
- AU
- Australia
- Prior art keywords
- diabetes
- digenic
- diagnosis
- treatment
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 2
- 206010022489 Insulin Resistance Diseases 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 230000035772 mutation Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35040502P | 2002-01-18 | 2002-01-18 | |
| US60/350,405 | 2002-01-18 | ||
| PCT/US2003/001625 WO2003061583A2 (en) | 2002-01-18 | 2003-01-17 | Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003205230A1 true AU2003205230A1 (en) | 2003-09-02 |
Family
ID=27613388
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003205230A Abandoned AU2003205230A1 (en) | 2002-01-18 | 2003-01-17 | Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003205230A1 (en) |
| WO (1) | WO2003061583A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2574424A1 (en) * | 2004-07-28 | 2006-02-02 | F. Hoffmann-La Roche Ag | Insulin promoter factor 1 as target/marker of beta cell failure |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6294559B1 (en) * | 1996-05-02 | 2001-09-25 | Merck & Co., Inc. | Antiproliferative agents associated with peroxisome proliferator activated receptors gamma1 and gamma2 |
| JP4296608B2 (en) * | 1997-08-27 | 2009-07-15 | 田辺三菱製薬株式会社 | PPAR agonist and antagonist screening method |
-
2003
- 2003-01-17 AU AU2003205230A patent/AU2003205230A1/en not_active Abandoned
- 2003-01-17 WO PCT/US2003/001625 patent/WO2003061583A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003061583A2 (en) | 2003-07-31 |
| WO2003061583A3 (en) | 2004-02-26 |
| WO2003061583A9 (en) | 2003-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003243551A1 (en) | Use of an anti-endotoxin drug in the prevention and treatment of disease | |
| IL161155A0 (en) | Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors | |
| IL160917A0 (en) | Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions | |
| AU2003291609A1 (en) | Cb 1/cb 2 receptor ligands and their use in the treatment of pain | |
| HUP0203367A3 (en) | Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes | |
| WO2005011680A8 (en) | Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity | |
| IL219670A0 (en) | [ 1,2,4] triazolo [4,3-a] pyridines and use thereof in the preparation of a medicament | |
| AU3791799A (en) | Phenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia | |
| AU2002308348A1 (en) | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours | |
| IL148401A0 (en) | Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases | |
| Gates | Update on advances in alternative insulin therapy | |
| AU2003286285A1 (en) | Use of fgf-18 in the diagnosis and treatment of memory disorders | |
| AU2003252182A1 (en) | Therapeutic treatment for the metabolic syndrome and type 2 diabetes | |
| AU2003219462A1 (en) | Defibrillator/monitor with patient specific treatment algorithms | |
| HUP0201997A2 (en) | Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications | |
| IL160018A0 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
| AU2003243427A1 (en) | Methods of diagnosing and treating diabetes and insulin resistance | |
| AU2003205230A1 (en) | Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes | |
| AU4073299A (en) | Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia | |
| AU2003232022A1 (en) | USE OF PARATHYROID HORMONE-RELATED PROTEIN (PTHrP) IN THE DIAGNOSIS AND TREATMENT OF CHRONIC LUNG DISEASE AND OTHER PATHOLOGIES | |
| EP1765832B8 (en) | Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias | |
| AU2003237483A1 (en) | Methods of diagnosing and treating diabetes and insulin resistance | |
| AU2003271016A1 (en) | Use of n-acetyl-d-aminoglycosamine in preparation of drugs for the treatment of cacer and metastasis | |
| AU2003240253A1 (en) | Polymorphisms in the human gene for htr3b and their use in diagnostic and therapeutic applications | |
| AU2003244498A1 (en) | Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |